Home › Sezary Syndrome
Sezary Syndrome clinical trials recruiting in the U.S.
13 studies for Sezary Syndrome are recruiting participants at sites across the United States.
Cities with the most studies
- Baldwin Park, CA7 studies
- Mountain View, CA5 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Houston, TX4 studies
- Boston, MA4 studies
- Pittsburgh, PA3 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
- Tampa, FL3 studies
By state
- California9 studies
- Florida3 studies
- Georgia4 studies
- Massachusetts4 studies
- Missouri3 studies
- New Jersey3 studies
- New York5 studies
- Pennsylvania6 studies
- Texas4 studies
Recently updated studies
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07003100A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06854653Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT04930653A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07192471Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT03011814Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT04256018Registry of Older Patients With Cancer
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825A Registry for People With T-cell Lymphoma
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT03587844Extracorporeal Photopheresis in Sezary Syndrome
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Dec 30, 2025 · NCT05157581Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT00177268Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Oct 27, 2025 · NCT01137643Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT04234048From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.